How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies

Triple-negative breast cancer (TNBC) is a long-lasting orphan disease in terms of little therapeutic progress during the past several decades and still the standard of care remains chemotherapy. Experimental discovery of molecular signatures including the ‘BRCAness’ highlighted the innate heterogene...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ESMO open 2018-01, Vol.3 (Suppl 1), p.e000357-e000357, Article e000357
Hauptverfasser:	Park, Ji Hyun, Ahn, Jin-Hee, Kim, Sung-Bae
Format:	Artikel
Sprache:	eng
Schlagworte:	Review triple-negative breast cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!